| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 8,110,750 | 7,472,224 | 5,925,276 | | Cost of Revenue | 7,092,652 | 5,742,434 | 4,482,257 | | | Gross Profit | 1,018,098 | 1,729,791 | 1,443,019 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 849,246 | 749,252 | 775,738 | | Non Recurring | 285,038 | (2,879) |
-
| | Others | 842,938 | 761,453 | 636,641 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (959,125) | 221,965 | 30,640 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 434,966 | 468,197 | 183,582 | | Earnings Before Interest And Taxes | (500,981) | 714,839 | 214,479 | | Interest Expense | 192,030 | 314,096 | 178,070 | | Income Before Tax | (693,011) | 400,743 | 36,409 | | Income Tax Expense | 9,095 | 117,632 | 21,794 | | Minority Interest |
-
|
-
| (2,051) | | | | Net Income From Continuing Ops | (702,106) | 283,112 | 27,691 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (702,106) | 283,112 | 27,691 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($702,106) | $283,112 | $27,691 |
|
0.51% Nasdaq 
Income Statement
